Find Clinical Trials
Effects of oral chronic administration of ivabradine (7.5 mg bid) in comparison to placebo (bid) on top of beta-blockers, on central aortic blood pressure. Randomized, cross-over, double blind, multicentre, study over 10 weeks in patients with stable coronary artery disease, type II diabetes and a resting heart rate equal or superior to 70 bpm, already treated with beta-blockers.
Servier Protocol Code:
CL2-16257-096
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2011-004779-35
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Coronary Artery Disease
- IVABRADINE
- S016257
Other study id numbers
Other identification numbers the study may be known by.
- CL2-16257-096